{"count": 2, "results": [{"_id": "40570636", "pmid": 40570636, "title": "Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.", "journal": "Biochem Biophys Res Commun", "authors": ["Yan C", "Ye Y", "Liu N", "Zhang D", "Du W", "Li Y", "Li G", "Li C", "Li J", "Ma S", "Dai Z", "Xiong Z", "Wang Y", "Men C", "Bi R", "Duan Q", "Xu W", "Husilengtu", "Cao Y", "Du J", "Shi C"], "date": "2025-06-24T00:00:00Z", "doi": "10.1016/j.bbrc.2025.152241", "meta_date_publication": "2025 Jun 24", "meta_volume": "777", "meta_issue": "", "meta_pages": "152241", "score": 50247.914, "text_hl": "Moreover, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly improved @<m>DISEASE_Muscular_Dystrophy_Congenital_Megaconial_Type</m> @DISEASE_MESH:C566527 @@@mitochondrial structural anomalies and@@@ dysfunction associated with @DISEASE_Immunologic_Deficiency_Syndromes @DISEASE_MESH:D007153 @@@PDCD10 deficiency@@@, characterized by the presence of mitochondrial puncta and the loss of cristae, followed by impaired mitochondrial membrane potential and increased mitoROS in endothelial cells with the mutation. ", "citations": {"NLM": "Yan C, Ye Y, Liu N, Zhang D, Du W, Li Y, Li G, Li C, Li J, Ma S, Dai Z, Xiong Z, Wang Y, Men C, Bi R, Duan Q, Xu W, Husilengtu, Cao Y, Du J, Shi C. Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage. Biochem Biophys Res Commun. 2025 Jun 24;777():152241. PMID: 40570636", "BibTeX": "@article{40570636, title={Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.}, author={Yan C and Ye Y and Liu N and Zhang D and Du W and Li Y and Li G and Li C and Li J and Ma S and Dai Z and Xiong Z and Wang Y and Men C and Bi R and Duan Q and Xu W and Husilengtu and Cao Y and Du J and Shi C}, journal={Biochem Biophys Res Commun}, volume={777}, pages={152241}}"}}, {"_id": "27018597", "pmid": 27018597, "pmcid": "PMC4809545", "title": "Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice", "journal": "PLoS One", "authors": ["Zhou W", "Kavelaars A", "Heijnen CJ"], "date": "2016-03-28T00:00:00Z", "doi": "10.1371/journal.pone.0151890", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "3", "meta_pages": "e0151890", "score": 50049.504, "text_hl": "Co-administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ prevented all of these @<m>DISEASE_Muscular_Dystrophy_Congenital_Megaconial_Type</m> @DISEASE_MESH:C566527 @@@structural abnormalities@@@ in cisplatin-treated @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Zhou W, Kavelaars A, Heijnen CJ. Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice PLoS One. 2016;11(3):e0151890. PMID: 27018597", "BibTeX": "@article{27018597, title={Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice}, author={Zhou W and Kavelaars A and Heijnen CJ}, journal={PLoS One}, volume={11}, number={3}, pages={e0151890}}"}}]}